0001213900-20-045807.txt : 20201231 0001213900-20-045807.hdr.sgml : 20201231 20201231172400 ACCESSION NUMBER: 0001213900-20-045807 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201229 FILED AS OF DATE: 20201231 DATE AS OF CHANGE: 20201231 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danenberg Noam CENTRAL INDEX KEY: 0001720898 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52545 FILM NUMBER: 201429498 MAIL ADDRESS: STREET 1: 4 BOROCHOV ST CITY: HOD HASHARON STATE: L3 ZIP: 4520404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Wize Pharma, Inc. CENTRAL INDEX KEY: 0001218683 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880445167 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 24 HANAGAR ST CITY: HOD HASHARON STATE: L3 ZIP: 4527713 BUSINESS PHONE: 972 472 260 0536 MAIL ADDRESS: STREET 1: 24 HANAGAR ST CITY: HOD HASHARON STATE: L3 ZIP: 4527713 FORMER COMPANY: FORMER CONFORMED NAME: OphthaliX, Inc. DATE OF NAME CHANGE: 20120207 FORMER COMPANY: FORMER CONFORMED NAME: DENALI CONCRETE MANAGEMENT INC DATE OF NAME CHANGE: 20030213 4 1 ownership.xml X0306 4 2020-12-29 0 0001218683 Wize Pharma, Inc. WIZP 0001720898 Danenberg Noam C/O WIZE PHARMA, INC. 24 HANAGAR STREET HOD HASHARON L3 4527708 ISRAEL 1 1 0 0 Chief Executive Officer Common Stock 2020-12-29 4 X 0 125000 A 1077681 D Common Stock 2020-12-29 4 S 0 962 D 1076719 D Common Stock 2020-12-29 4 X 0 1505162 A 2581881 I See Footnote Common Stock 2020-12-29 4 S 0 12543 D 2569338 I See Footnote Common Stock 2020-12-29 4 X 0 173607 A 2742945 I See Footnote Common Stock 2020-12-29 4 S 0 1447 D 2741498 I See Footnote Common Stock 2020-12-29 4 X 0 63236 A 2804734 I See Footnote Common Stock 2020-12-29 4 S 0 507 D 2804227 I See Footnote Warrant (right to buy) 0.16 2020-12-29 4 X 0 125000 0 D 2019-04-21 2023-10-23 Common Stock 125000 0 D Warrant (right to buy) 0.27 2020-12-29 4 X 0 1505162 0 D 2024-12-12 Common Stock 1505162 0 I See Footnote Warrant (right to buy) 0.16 2020-12-29 4 X 0 173607 0 D 2019-05-31 2021-05-30 Common Stock 173607 0 I See Footnote Future Investment Rights 0.27 2020-12-29 4 X 0 63236 0 D 2019-12-13 2024-12-12 Common Stock 63236 0 I See Footnote On December 23, 2020 the registrant has voluntary reduced the exercise price of warrants to $0.001. The reporting person exercised a warrant to purchase shares of the registrant's common stock for the reduced exercise price. On December 29, 2020 the reporting person exercised a warrant to purchase 125,000 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 962 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 124,038 shares. On December 29, 2020 the reporting person exercised a warrant to purchase 1,505,162 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 12,543 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,492,619 shares. On December 29, 2020 the reporting person exercised a warrant to purchase 173,607 shares of the registrant's common stock for $0.16 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 1,447 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,160 shares. On December 29, 2020 the reporting person exercised a warrant to purchase 63,236 shares of the registrant's common stock for $0.27 a share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding of 507 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 62,729 shares. Securities held by Mobigo Inc. Exercisable five days following the public announcement of positive clinical data results for LO2A. /s/ Noam Dannenberg 2020-12-31